Mystical Experience with Cancer Patients: Insights from Psychedelic-Assisted Psychotherapy and Guided Imagery

Psychedelic-assisted psychotherapy for cancer patients alleviates mental distress, with the intensity of the mystical experience directly correlating with relief. This article proposes combining guided imagery with psychedelic-assisted psychotherapy to potentially reduce or eliminate physiological tumors. It compares the two modalities, discusses the literature on mystical experience, and presents anecdotal outcomes of cancer remission among private therapy guided imagery patients.

Study at a glance

Abstract

Background: In controlled, clinical studies of the impact of psilocybin on patients with life-threatening cancers, Johns Hopkins and NYU researchers found that the “intensity of the mystical experience” induced by psychedelic-assisted psychotherapy was directly correlated with the alleviation of cancer-related mental distress. Objective: The purpose of this article is to explore the proposition that the combination of psychotherapeutic guided imagery and psychedelic-assisted psychotherapy could not only alleviate cancer-related psychological distress but also reduce or eliminate physiological tumors. Methods: The literature surrounding “mystical experience” is discussed; the modalities of psychedelic-assisted psychotherapy and guided imagery psychotherapy with cancer patients are compared; and the anecdotal outcomes of cancer remission among private therapy guided imagery patients are presented.